2,071
Views
0
CrossRef citations to date
0
Altmetric
Pregnancy, Childbirth & Women’s Health

Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe)

, , , , , , , , , , , , ORCID Icon & show all
Pages 2884-2896 | Received 21 Dec 2021, Accepted 02 Oct 2022, Published online: 21 Oct 2022

References

  • Harlow BL, EG, Stewart 'A. Population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003;58(1972):82–88.
  • Lev-Sagie A, Witkin SS. Recent advances in understanding provoked vestibulodynia. F1000Res. 2016;5:2581.
  • Xie Y, Shi L, Xiong X, et al. Economic burden and quality of life of vulvodynia in the United States. Curr Med Res Opin. 2012;28(4):601–608.
  • Williams RE, Hartmann KE, Sandler RS, et al. Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain. Obstet Gynecol. 2004;104(3):452–458.
  • Zolnoun DA, Rohl J, Moore CG, et al. Overlap between orofacial pain and vulvar vestibulitis syndrome. Clin J Pain. 2008;24(3):187–191.
  • Goldstein AT, Pukall CF, Brown C, et al. Vulvodynia: assessment and treatment. J Sex Med. 2016;13(4):572–590.
  • Bornstein J, Goldstein AT, Stockdale CK, et al. The international society for the study of women’s sexual health consensus vulvar pain terminology committee of the international society for the study of vulvovaginal disease, and society the international pelvic pain. 2016. '2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Obstet Gynecol. 2016;127:745–751.
  • Ciszek BP, Khan AA, Dang H, et al. MicroRNA expression profiles differentiate chronic pain condition subtypes. Transl Res. 2015;166(6):706–720.e11.
  • Corbett SH, Cuddeback G, Lewis J, et al. Trends in pharmacy compounding for women’s health in North Carolina: focus on vulvodynia. South Med J. 2014;107(7):433–436.
  • Updike GM, Wiesenfeld HC. Insight into the treatment of vulvar pain: a survey of clinicians. Am J Obstet Gynecol. 2005;193(4):1404–1409.
  • Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102:84–87.
  • Butterworth JF, Strichartz GR. Molecular mechanisms of local anesthesia: a review. Anesthesiology. 1990;72(4):711–734.
  • Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain. 2006;7(1 Suppl 1):S3–s12.
  • Bazin S, Lefebvre J, Fortier M, et al. Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial]. J Obstet Gynaecol Can. 2011;[33(8):838–843.
  • Gardella B, Iacobone AD, Porru D, et al. Effect of local estrogen therapy (LET) on urinary and sexual symptoms in premenopausal women with interstitial cystitis/bladder pain syndrome (IC/BPS). Gynecol Endocrinol. 2015;31(10):828–832.
  • Bhattacherjee A, Rumi MA, Staecker H, et al. Bone morphogenetic protein 4 mediates estrogen-regulated sensory axon plasticity in the adult female reproductive tract. J Neurosci. 2013;33(3):1050–161a.
  • Ting AY, Blacklock AD, Smith PG. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol Reprod. 2004;71(4):1397–1404.
  • Wesselmann U, Garrett-Mayer E, Kaplan Gilpin AM, et al. The influence of the ovarian cycle on mechanical hyperalgesia in vulvar vestibulitis– a neuropathic urogenital pain syndrome. Ann Neurol. 2006;60:S29.
  • Perez-Lopez FR, Bueno-Notivol J, Hernandez AV, et al. Systematic review and Meta-analysis of the effects of treatment modalities for vestibulodynia in women. Eur J Contracept Reprod Health Care. 2019;24(5):337–346.
  • Walker EA, Roy-Byrne PP, Katon WJ, et al. An open trial of nortriptyline in women with chronic pelvic pain. Int J Psychiatry Med. 1991;21(3):245–252.
  • Stolar AG, Stewart JT. Nortriptyline for depression and vulvodynia. Am J Psychiatry. 2002;159(2):316–317.
  • van Beekhuizen HJ, Oost J, van der Meijden WI. Generalized unprovoked vulvodynia; a retrospective study on the efficacy of treatment with amitriptyline, gabapentin or pregabalin. Eur J Obstet Gynecol Reprod Biol. 2018;220:118–121.
  • Brown CS, Bachmann GA, Wan J, Gabapentin (GABA) Study Group, et al. Gabapentin for the treatment of vulvodynia: a randomized controlled trial. Obstet Gynecol. 2018;131(6):1000–1007.
  • Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3–S14.
  • Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66(6):355–474.
  • Dick IE, Brochu RM, Purohit Y, et al. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain. 2007;8(4):315–324.
  • Obuchowicz E, Kowalski J, Labuzek K, et al. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol. 2006;9(1):27–35.
  • De Andres J, Sanchis-Lopez N, Asensio-Samper JM, et al. Vulvodynia–an evidence-based literature review and proposed treatment algorithm. Pain Pract. 2016;16(2):204–236.
  • Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol. 2012;206:170 e1–9.
  • Foster DC, Kotok MB, Huang LS, et al. The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness. Obstet Gynecol. 2009;113(4):825–832.
  • Kaarbo MB, Danielsen KG, Haugstad GK, et al. The tampon test as a primary outcome measure in provoked vestibulodynia: a mixed methods study. J Sex Med. 2021;18(6):1083–1091.
  • Lamvu G, Alappattu M, Witzeman K, et al. Patterns in vulvodynia treatments and 6-Month outcomes for women enrolled in the national vulvodynia registry-an exploratory prospective study. J Sex Med. 2018;15(5):705–715.
  • Hays RD, Bjorner JB, Revicki DA, et al. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873–880.
  • Fenton BW, Palmieri P, Diantonio G, et al. Application of patient-reported outcomes measurement information system to chronic pelvic pain. J Minim Invasive Gynecol. 2011;18(2):189–193.
  • Sung VW, Wohlrab KJ, Madsen A, et al. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2016;215(5):659.e1-59–659.e7.
  • Ware JE, Kosinski M, Keller SD. 1995. SF-12: how to score the SF-12 physical and mental health summary scales (The Health Institute, New England Medical Center: Boston, Massachusetts).
  • Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233.
  • Smith KB, Pukall CF. Sexual function, relationship adjustment, and the relational impact of pain in male partners of women with provoked vulvar pain. J Sex Med. 2014;11(5):1283–1293.
  • Hardt J, Gerbershagen HU. Cross-validation of the SCL-27: a short psychometric screening instrument for chronic pain patients. Eur J Pain. 2001;5(2):187–197.
  • Slade GD, Conrad MS, Diatchenko L, et al. Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness. Pain. 2011;152(12):2802–2812.
  • Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain. 2013;14(12 Suppl):T75–90.
  • Geller EJ, Babb E, Nackley AG, et al. Incidence and risk factors for pelvic pain after mesh implant surgery for the treatment of pelvic floor disorders. J Minim Invasive Gynecol. 2017;24(1):67–73.
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–396.
  • Hays R, Stewart A. 1992. Sleep measures. In: Ware J Stewart A, editors, Measuring functioning and well-being: the medical outcomes study approach. Durham, NC: Duke University Press.
  • Viala-Danten M, Martin S, Guillemin I, et al. Evaluation of the reliability and validity of the medical outcomes study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial. Health Qual Life Outcomes. 2008;6(1):113.
  • Cappelleri JC, Bushmakin AG, McDermott AM, et al. Measurement properties of the medical outcomes study sleep scale in patients with fibromyalgia. Sleep Med. 2009;10(7):766–770.
  • Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol. 1997;89(2):291–296.
  • Foster DC, Piekarz KH, Murant TI, et al. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis. Am J Obstet Gynecol. 2007;196:346–e1348.
  • Gerber S, Bongiovanni AM, Ledger WJ, et al. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2002;186(4):696–700.
  • Garry DJ, Baker DA, Persad MD, et al. Progesterone effects on vaginal cytokines in women with a history of preterm birth. PLOS One. 2018;13(12):e0209346.
  • Ventolini G, Gygax SE, Adelson ME, et al. Vulvodynia and fungal association: a preliminary report. Med Hypotheses. 2013;81(2):228–230.
  • Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 2014;13(7):533–548.
  • Institute of Medicine Committee on Advancing Pain Research, Care, and Education. 2011. The national academies collection: reports funded by national institutes of health. In: Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press (US) National Academy of Sciences.
  • Atzeni F, Salaffi F, Bazzichi L, et al. The evaluation of the fibromyalgia patients. Reumatismo. 2008;60(Suppl 1):36–49.
  • Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106(3):337–345.
  • Giesecke J, Reed BD, Haefner HK, et al. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol. 2004;104:126–133.
  • Gilron I, Tu D, Holden RR, et al. Combination of morphine with nortriptyline for neuropathic pain. Pain. 2015;156(8):1440–1448.
  • Harlow BL, Kunitz CG, Nguyen RH, et al. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions. Am J Obstet Gynecol. 2014;210:40 e1–8.
  • Hudson B, Williman JA, Stamp LK, et al. Nortriptyline in knee osteoarthritis (NortIKA study): study protocol for a randomised controlled trial. Trials. 2015;16:448.
  • Harlow BL, Vitonis AF, Stewart EG. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. J Reprod Med. 2008;53(2):102–110.
  • Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283–291.
  • Baker TB, Smith SS, Bolt DM, et al. Implementing clinical research using factorial designs: a primer. Behav Ther. 2017;48(4):567–580.
  • Fleischmann R, Decker AM, Kraft A, et al. Mobile electronic versus paper case report forms in clinical trials: a randomized controlled trial. BMC Med Res Methodol. 2017;17(1):153.
  • Ajit SK. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors. 2012;12(3):3359–3369.
  • Akopians AL, Rapkin AJ. Vulvodynia: the role of inflammation in the etiology of localized provoked pain of the vulvar vestibule (vestibulodynia). Semin Reprod Med. 2015;33(04):239–245.
  • Kiefe CI, Sales A. A state-of-the-art conference on implementing evidence in health care. Reasons and recommendations. J Gen Intern Med. 2006;21(Suppl 2):S67–S70.